XML 30 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share

NOTE 8. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share (“EPS”) for the periods indicated.

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Basic (loss) earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to common stockholders (000's)

 

$

(16,410

)

 

$

(5,233

)

 

$

(25,509

)

 

$

6,519

 

Weighted average shares outstanding

 

 

27,938,028

 

 

 

27,739,839

 

 

 

27,902,814

 

 

 

28,053,959

 

Basic (loss) earnings per share:

 

$

(0.59

)

 

$

(0.19

)

 

$

(0.91

)

 

$

0.23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted (loss) earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to common stockholders (000's)

 

$

(16,410

)

 

$

(5,233

)

 

$

(25,509

)

 

$

6,519

 

Weighted average shares outstanding

 

 

27,938,028

 

 

 

27,739,839

 

 

 

27,902,814

 

 

 

28,053,959

 

Weighted average dilutive shares

 

 

 

 

 

 

 

 

 

 

 

19,611

 

Total weighted average dilutive shares

 

 

27,938,028

 

 

 

27,739,839

 

 

 

27,902,814

 

 

 

28,073,570

 

Diluted (loss) earnings per share:

 

$

(0.59

)

 

$

(0.19

)

 

$

(0.91

)

 

$

0.23

 

Due to the net loss for the three and nine months ended September 30, 2021, the number of dilutive shares is the same as the number of basic shares due to the antidilutive impact of the convertible debt and restricted stock under the if-converted method. The convertible notes were excluded from the computations because the conversion price on these notes was greater than the average market price of the Company’s common shares during each of the respective periods, and therefore, would be anti-dilutive to earnings per share under the treasury method. The Company had 2,677,355 and 1,819,503 antidilutive shares as of September 30, 2021 and 2020, respectively.